Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROSHARES TRUST (ZBIO) Short-term Investments: 2024

Historic Short-term Investments for Zenas BioPharma (ZBIO) over the last 1 years, with Dec 2024 value amounting to $31.0 million.

  • Zenas BioPharma's Short-term Investments rose 196887.64% to $175.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $175.3 million, marking a year-over-year increase of 196887.64%. This contributed to the annual value of $31.0 million for FY2024, which is N/A change from last year.
  • Per Zenas BioPharma's latest filing, its Short-term Investments stood at $31.0 million for FY2024.
  • Over the past 5 years, Zenas BioPharma's Short-term Investments peaked at $31.0 million during FY2024, and registered a low of $31.0 million during FY2024.
  • For the 1-year period, Zenas BioPharma's Short-term Investments averaged around $31.0 million, with its median value being $31.0 million (2024).